¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦29Â÷ ´ëÇÑÀÇ·á°ü·Ã°¨¿°°ü¸®ÇÐȸ Çмú´ëȸ¿Í ¿¬¼ö±³À° (1ÀÏÂ÷) : 2024-05-23

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦29Â÷ ´ëÇÑÀÇ·á°ü·Ã°¨¿°°ü¸®ÇÐȸ Çмú´ëȸ¿Í ¿¬¼ö±³À° (1ÀÏÂ÷) : 2024-05-23
±³À°ÀÏÀÚ : 2024-05-23
±³À°Àå¼Ò : ´õÄÉÀÌÈ£ÅÚ ¼­¿ï, ±×·£µåº¼·ë(2Ãþ) Å©¸®½ºÅ»º¼·ë(3Ãþ)

±³À°ÁÖÁ¦ : "Á¦29Â÷ ´ëÇÑÀÇ·á°ü·Ã°¨¿°°ü¸®ÇÐȸ Çмú´ëȸ¿Í ¿¬¼ö±³À° (1ÀÏÂ÷)"

ÁÖÃÖ±â°ü : ´ëÇÑÀÇ·á°ü·Ã°¨¿°°ü¸®ÇÐȸ
´ã´çÀÚ : ´ëÇÑÀÇ·á°ü·Ã°¨¿°°ü¸®ÇÐȸ
¿¬¶ôó : 02-585-8383  

À̸ÞÀÏ : info@koshic.org

±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú

Âü¼®¿¹»óÀÎ : 700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 11 ½Ã°£ 40ºÐ

¼¼ºÎ¼ö°­·á : 250,000¿ø  

ºñ°í ȸ¿ø: 18¸¸¿ø, ºñȸ¿ø:20¸¸¿ø, ÇöÀåµî·Ï:25¸¸¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 23ÀÏ ±×·£µåº¼·ë 09:00~09:30 °¨¿°°ü¸® ½ÇÅÂÁ¶»çÀÇ °³¿ä¿Í ÀÇ¹Ì ¾öÁß½Ä(°¡ÃµÀÇ´ë)

±³À°½Ã°£ 05¿ù 23ÀÏ ±×·£µåº¼·ë 09:30~10:00 ±Þ¼º±â/¿ä¾çº´¿ø ½ÇÅÂÁ¶»ç °á°ú¿Í ÇâÈÄ °úÁ¦ ÃÖÁö¿¬(Áß¾Ó´ëÇб³º´¿ø)

±³À°½Ã°£ 05¿ù 23ÀÏ ±×·£µåº¼·ë 10:00~10:30 ÀÇ¿ø ½ÇÅÂÁ¶»ç °á°ú¿Í ÇâÈÄ °úÁ¦ ÀÌÀç°©(ÇѸ²ÀÇ´ë)

ÈÞ½Ä 05¿ù 23ÀÏ ±×·£µåº¼·ë 10:30~10:40 break ()

±³À°½Ã°£ 05¿ù 23ÀÏ ±×·£µåº¼·ë 10:40~11:10 °¨¿°°ü¸® ÃֽŠÁö°ß-°³Á¤µÈ The Society for Healthcare Epidemiology of America (SHEA) Áöħ Áß½ÉÀ¸·Î(¼ÕÀ§»ý) ±èÁöÈñ(ÀÌ´ë¼­¿ïº´¿ø)

±³À°½Ã°£ 05¿ù 23ÀÏ ±×·£µåº¼·ë 11:10~11:40 °¨¿°°ü¸® ÃֽŠÁö°ß-°³Á¤µÈ The Society for Healthcare Epidemiology of America (SHEA) Áöħ Áß½ÉÀ¸·Î Central line-associated bloodstream infection (CLABSI) ȲÁÖÈñ(ÀüºÏÀÇ´ë)

±³À°½Ã°£ 05¿ù 23ÀÏ ±×·£µåº¼·ë 11:40~12:10 °¨¿°°ü¸® ÃֽŠÁö°ß-°³Á¤µÈ The Society for Healthcare Epidemiology of America (SHEA) Áöħ Áß½ÉÀ¸·Î Clostridioides difficile infection (CDI) ±è´Ù¿µ(Á¶¼±ÀÇ´ë)

±³À°½Ã°£ 05¿ù 23ÀÏ ±×·£µåº¼·ë 13:00~13:30 The Korea Global Antimicrobial Resistance Surveillance System (Kor-GALASS) ±èµµ±Õ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 05¿ù 23ÀÏ ±×·£µåº¼·ë 13:30~14:00 ÀÎÇ÷翣ÀÚ ¹× È£Èí±â¹ÙÀÌ·¯½º°¨¿°Áõ º´¿øü°¨½Ã(KINRESS) ±èÀºÁø(Áúº´°ü¸®Ã»)

±³À°½Ã°£ 05¿ù 23ÀÏ ±×·£µåº¼·ë 14:00~14:30 KOrean National healthcare-associated Infections Surveillance system (KONIS) update Á¤µÎ·Ã(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 05¿ù 23ÀÏ ±×·£µåº¼·ë 14:30~15:10 ÀÇ·áÇöÀå¿¡¼­ È£Èí±â¹ÙÀÌ·¯½ºÀÇ °¨¿° ¿¹¹æ°ú °ü¸® ±è¿ìÁÖ(°í·ÁÀÇ´ë)

ÈÞ½Ä 05¿ù 23ÀÏ ±×·£µåº¼·ë 15:10~15:30 break ()

±³À°½Ã°£ 05¿ù 23ÀÏ ±×·£µåº¼·ë 15:30~16:00 Ä«¹ÙÆä³Û°è Ç×»ýÁ¦ Àå±â»ç¿ë ´ÜÃàÀ» À§ÇÑ ÁßÀçÈ¿°ú ºÐ¼® ÃÖ½ÂÁø(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 05¿ù 23ÀÏ ±×·£µåº¼·ë 16:00~16:30 Àڿܼ±°ú °ú»êÈ­¼ö¼Ò °ø°£¼Òµ¶±â°è¸¦ »ç¿ëÇÑ ÀÇ·á±â°ü ȯ°æ¼Òµ¶ ½Ã CPE ¿À¿°Á¦°Å È¿°ú ºñ±³ ¹Ú¼Ò¿¬(¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 05¿ù 23ÀÏ ±×·£µåº¼·ë 16:30~17:00 °¨¿°¾à·á Àü¹® ¾à»ç°¡ ¼öÇàÇÏ´Â Ç×»ýÁ¦ »ç¿ë·® º¸°íÀÇ º´¿ø ³» Ç×»ýÁ¦ »ç¿ë °³¼± È¿°ú¿¡ ´ëÇÑ ¿¬±¸ ±è¿ë±Õ(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 05¿ù 23ÀÏ ±×·£µåº¼·ë 17:00~17:30 ÁßȯÀÚ½ÇÀÇ Áß½ÉÁ¤¸Æ°ü °ü·Ã Ç÷·ù°¨¿° À§Çè¿äÀÎ ¹Î°æ¿ø(¿øÁֱ⵶º´¿ø)

±³À°½Ã°£ 05¿ù 23ÀÏ Å©¸®½ºÅ»º¼·ë 09:00~09:30 Respiratory Syncytial Virus(RSV) vaccine À±±â¿í(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 05¿ù 23ÀÏ Å©¸®½ºÅ»º¼·ë 09:30~10:00 Rotavirus vaccine µµÀÔ°ú ¿ªÇÐÀÇ º¯È­ ±è½Â¿¬(ÀÎÁ¦ÀÇ´ë »ó°è¹éº´¿ø)

±³À°½Ã°£ 05¿ù 23ÀÏ Å©¸®½ºÅ»º¼·ë 10:00~10:30 Updated COVID vaccine ³ëÁöÀ±(°í·ÁÀÇ´ë)

ÈÞ½Ä 05¿ù 23ÀÏ Å©¸®½ºÅ»º¼·ë 10:30~10:40 break ()

±³À°½Ã°£ 05¿ù 23ÀÏ Å©¸®½ºÅ»º¼·ë 10:40~11:25 °¨¿°°ü¸®¸¦ À§ÇÑ Åë°èÀû ±â¹ý_ÀÌ·Ð À§ÁÖ ÃÖÁ¤½Ç(°¡Ãµ´ëÇб³)

±³À°½Ã°£ 05¿ù 23ÀÏ Å©¸®½ºÅ»º¼·ë 11:25~12:10 ÀÇ·á±â°ü À¯Çà ¹ß»ý Áõ·Ê¸¦ ÅëÇØ Åë°èÀû ±â¹ý Ç®ÀÌ_Áõ·Ê À§ÁÖ Á¤ÀçÈÆ(°¡ÃµÀÇ´ë)

½Ä»ç 05¿ù 23ÀÏ Å©¸®½ºÅ»º¼·ë 12:10~13:00 LUNCH ()

±³À°½Ã°£ 05¿ù 23ÀÏ Å©¸®½ºÅ»º¼·ë 13:00~13:30 Carbapenemase-producing Enterobacterales (CPE) ¿¹¹æÀû ¼±º°À» À§ÇÑ ½Å¼Ó°Ë»ç Á¤Çý¼±(ÀÌÈ­ÀÇ´ë)

±³À°½Ã°£ 05¿ù 23ÀÏ Å©¸®½ºÅ»º¼·ë 13:30~14:00 Surgical Site Infection (SSI) ¿¹¹æÀ» À§ÇÑ ¼ö¼ú Àü °Ë»ç ¹× Ä¡·á ÀåÁ¤Çö(ÀÎÁ¦ÀÇ´ë)

±³À°½Ã°£ 05¿ù 23ÀÏ Å©¸®½ºÅ»º¼·ë 14:00~14:30 ÀÓ»ó¹Ì»ý¹° °Ë»ç °á°ú¿¡ ±Ù°ÅÇÑ À¯ÇàÀÇ Á¶±â ¹ß°ß ¾î¿µ(¿¬¼¼¿øÁÖÀÇ´ë)

ÈÞ½Ä 05¿ù 23ÀÏ Å©¸®½ºÅ»º¼·ë 14:30~15:30 break ()

±âŸ 05¿ù 23ÀÏ Å©¸®½ºÅ»º¼·ë 15:30~17:00 ±¸¿¬¹ßÇ¥ ±è½Å¿ì, ½Å¸íÁø(°æºÏÀÇ´ë/ºÐ´ç¼­¿ï´ëº´¿ø)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦29Â÷ ´ëÇÑÀÇ·á°ü·Ã°¨¿°°ü¸®ÇÐȸ Çмú´ëȸ¿Í ¿¬¼ö±³À° (1ÀÏÂ÷) : 2024-05-23""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѾฮÇÐȸ Frontiers in Epithelial Transport 2024(1ÀÏÂ÷) : 2024-05-23
´ÙÀ½±Û ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-05-20
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20664 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ)¼Ò¾Æû¼Ò³â°ú Çù·ÂÀÇ»ç Áý´ãȸ : 2024-05-28 0 22 2024-05-10
20663 ºÎ»ê ´ëÇѳ»°úÀÇ»çȸ Á¦1ȸ ÃÊÀ½ÆÄ ½ÇÀü ¾ÆÄ«µ¥¹Ì : 2024-05-27 0 20 2024-05-10
20662 ¼­¿ï ´ëÇѿ°èÁٱ⼼Æ÷Àç»ýÀÇÇÐȸ - Á¦20ȸ Ãá°èÇмú´ëȸ (ÇÏÀ̺긮µå) : 2024-05-26 0 15 2024-05-10
20661 ºÎ»ê ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ ºÎ¿ï°æÁöȸ 5¿ù ¿¬¼ö°­Á : 2024-05-26 0 12 2024-05-10
20660 ¼­¿ï ´ëÇѽŰæ±Ù°ñ°áÃÊÀ½ÆÄÇÐȸ Á¦1ȸ ÇÚÁî¿Â ¿öÅ©¼ó : 2024-05-25 0 23 2024-05-10
20659 ´ëÀü ´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ 2024 Áöȸ½ÉÆ÷Áö¾ö-´ëÀüÃæ³² : 2024-05-25 0 8 2024-05-10
20658 ºÎ»ê ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦32Â÷ Á¤±âÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-25 0 13 2024-05-10
20657 ´ë±¸ Ä¥°î°æºÏ´ëÇб³º´¿ø The 1st International Symposium on Precision Oncology in Breast Cancer : 2024-05-25 0 12 2024-05-10
20656 ¼­¿ï (¿Â¶óÀÎ)2024³â ´ëÇÑ°ñ´ë»çÇÐȸ Á¦1Â÷ FLS ÄÚµð³×ÀÌÅÍ ¿öÅ©¼ó : 2024-05-24 0 14 2024-05-10
20655 ¼­¿ï Á¦ 66ȸ Çѱ¹Ç×°ø¿ìÁÖÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-24 0 7 2024-05-10
20654 ´ëÀü °ø°ø±â°ü ÀçÁ÷ÀÇ»ç Ãá°è Çмú´ëȸ (2ÀÏÂ÷) : 2024-05-24 0 9 2024-05-10
20653 ºÎ»ê ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦32Â÷ Á¤±âÇмú´ëȸ(1ÀÏÂ÷) : 2024-05-24 0 12 2024-05-10
20652 ¼­¿ï Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦ 44 Â÷ KSTH Ãá°èÇмú´ëȸ : 2024-05-24 0 8 2024-05-10
20651 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-°³¿ø°¡¿¡¼­ ÀÇ·ÚµÈ ÀÌ°ú Áúȯ : 2024-05-23 0 13 2024-05-10
20650 °æ±â Çϳ²½ÃÀÇ»çȸ¿¬¼ö°­ÁÂ(¸¸¼º±âħ, ºÒ¸éÁõ) : 2024-05-23 0 6 2024-05-10
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷